Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 01, 2019 08:01 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-105

DEER PARK, Ill., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
July 30, 2019 08:01 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals to Report Second Quarter 2019 Financial Results on Tuesday, August 6, 2019

DEER PARK, Ill., July 30, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
July 12, 2019 16:01 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Provides Update on EM-100 Program

DEER PARK, Ill., July 12, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
June 13, 2019 16:01 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application and Provides Pipeline Update

Unique patent-pending formulation of lamotrigine addresses significant unmet need in pediatric epilepsy patientsNDA was submitted in May 2019; product launch anticipated in 1H 2020Lamotrigine market...
May 15, 2019 16:01 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals to Present at 20th Annual B. Riley FBR Investor Conference

DEER PARK, Ill., May 15, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
May 07, 2019 16:05 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Business Progress

– Four Products Currently Under Review with the FDA – – Expecting Multiple Product Launches in Second Half of 2019 – – Company to Host Conference Call and Webcast today at 4:30 p.m. ET (3:30 p.m....
April 30, 2019 16:30 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals to Report First Quarter 2019 Financial Results on Tuesday, May 7, 2019

DEER PARK, Ill., April 30, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
March 25, 2019 08:01 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Business Progress

DEER PARK, Ill., March 25, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
March 14, 2019 08:00 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Submits New Drug Application for DS-200

DEER PARK, Ill., March 14, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), today announced that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug...
February 21, 2019 08:00 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals to Present at the 8th Annual SVB Leerink Healthcare Conference

DEER PARK, Ill., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...